摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

bicyclo[3.3.1]non-6-en-3-one | 87012-22-4

中文名称
——
中文别名
——
英文名称
bicyclo[3.3.1]non-6-en-3-one
英文别名
——
bicyclo[3.3.1]non-6-en-3-one化学式
CAS
87012-22-4
化学式
C9H12O
mdl
——
分子量
136.194
InChiKey
HZSXYYPFQRHEOG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    100 °C (sublm)(Press: 5 Torr)
  • 沸点:
    223.7±19.0 °C(Predicted)
  • 密度:
    1.043±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Mechanism of Chorismate Mutase:  Contribution of Conformational Restriction to Catalysis in the Claisen Rearrangement
    作者:Nikolai A. Khanjin、James P. Snyder、F. M. Menger
    DOI:10.1021/ja992453d
    日期:1999.12.1
    The mechanism of the enzyme- and antibody-catalyzed Claisen rearrangement of chorismate to prephenate was investigated experimentally on model compounds and by using quantum chemistry calculations at the Becke3LYP/6-31G* level of theory. Conformational restriction of the allyl vinyl ether fragment to the reactive chairlike conformation in 1 induces a 2 × 105-fold rate acceleration (ΔΔG⧧ = 7.3 kcal/mol)
    通过在 Becke3LYP/6-31G* 理论水平上使用量子化学计算,在模型化合物上通过实验研究了酶和抗体催化的分支酸克莱森重排为 prephenate 的机制。烯丙基乙烯基醚片段对 1 中反应性椅子状构象的构象限制导致 C6D6 中 Claisen 重排相对于不受限制的类似物 3. 之间的直接关系加速(ΔΔG⧧ = 7.3 kcal/mol)在其他模型系统中观察到激活势垒降低和反应末端之间的距离。在一个构象受限模型中,反应中心从 4.0 压缩到 3.0 A 导致势垒从 24 kcal/mol 降低到 12 kcal/mol。进一步压缩将激活势垒降低到仅 4 kcal/mol。
  • COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION
    申请人:Xu Lifeng
    公开号:US20140045779A1
    公开(公告)日:2014-02-13
    This invention relates with anti-tumor activities of new compounds containing an adamantyl group or analogs thereof. The invention also relates with the medication applications of anti-tumor and other diseases by this kind of compounds with the combination of S, P, T structures containing adamantyl group and the formation of stereoisomer, tautomers, prodrug, pharmaceutically acceptable salts, complex salts or solvates to their anticancer application and anticancer agents, which have the following general formula:
    这项发明涉及含有金刚烷基团或其类似物的新化合物的抗肿瘤活性。该发明还涉及利用这种含有金刚烷基团的S、P、T结构的化合物与立体异构体、互变异构体、前药、药用盐、复杂盐或溶剂化物的结合来治疗抗肿瘤和其他疾病的药物应用,这些抗肿瘤剂具有以下一般公式:
  • Synthesis and evaluation of tacrine–Huperzine a hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of alzheimer’s disease
    作者:Albert Badia、Josep E. Baños、Pelayo Camps、Joan Contreras、Diana M. Görbig、Diego Muñoz-Torrero、Montserrat Simón、Nuria M. Vivas
    DOI:10.1016/s0968-0896(98)00015-7
    日期:1998.4
    Seventeen polycyclic compounds related to tacrine and huperzine A have been prepared as racemic mixtures and tested as acetylcholinesterase (AChE) inhibitors. The conjunctive pharmacomodulation of huperzine A (carbobicyclic substructure) and tacrine (4-aminoquinoline substructure) led to compound 7jy, 2.5 times less active than tacrine as AChE inhibitor, but much more active than its (Z)-stereoisomer (7iy). Derivatives 7dy and 7ey, lacking the ethylidene substituent, showed to be more active than tacrine. Many other structural modifications of 7jy led to less active compounds. Compounds 7dy and 7ey also showed to be much more active than tacrine in reversing the partial neuromuscular blockade induced by d-tubocurarine. (C) 1998 Elsevier Science Ltd. All rights reserved.
  • Efficient synthesis of barbaralane
    作者:James G. Henkel、Jeffrey T. Hane
    DOI:10.1021/jo00169a066
    日期:1983.10
  • HENKEL, J. G.;HANE, J. T., J. ORG. CHEM., 1983, 48, N 21, 3858-3859
    作者:HENKEL, J. G.、HANE, J. T.
    DOI:——
    日期:——
查看更多